Transapical Beating-Heart Mitral Valve Repair with NeoChord DS1000 Implantation: A Single-Center Retrospective Experience
This single-center retrospective study of 31 patients demonstrates that transapical beating-heart mitral valve repair with the NeoChord DS1000 system offers excellent early safety and procedural success, though time-to-event analysis reveals that mid-term durability is more limited than previously suggested, highlighting the importance of strict patient selection and ongoing surveillance.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart is a tireless pump, but its valves are the delicate gates that keep blood flowing in the right direction. When one of these gates, specifically the mitral valve located between the left chambers, fails to close tightly, blood leaks backward. This condition, known as mitral regurgitation, forces the heart to work harder and can eventually lead to heart failure. For decades, the standard solution has been open-heart surgery, where doctors stop the heart, use a machine to circulate blood, and either repair or replace the valve. While effective, this approach carries significant risks and requires a long recovery. In recent years, surgeons have sought ways to fix the valve without stopping the heart or using a machine, aiming for a less invasive path that preserves the body's natural rhythm.
A team of surgeons in Turkey recently explored one such approach, using a specialized tool to repair the leaking valve while the heart continued to beat. They focused on patients with a specific type of valve failure where the inner flaps of the valve droop or flap too loosely. Instead of opening the chest fully or stopping the heart, they made a small incision between the ribs and reached the heart from the bottom tip. Through this tiny opening, they threaded a device that could measure and replace the tiny, thread-like cords that hold the valve flaps in place. These artificial cords, made of a durable synthetic material, were tied to the valve and anchored to the heart muscle, pulling the loose flaps back into a tight seal. The entire procedure was guided by ultrasound images taken from inside the esophagus, allowing the surgeons to see the valve working in real time and adjust the tension of the new cords until the leak stopped.
The researchers reviewed the records of thirty-one patients who underwent this procedure between 2016 and 2022. These patients were carefully selected because their heart valves had a specific shape that made them suitable for this type of repair, and they did not have other severe complications like a widely stretched valve ring or heavy calcium buildup. The surgery was remarkably quick, taking an average of just over two hours, and the recovery was swift. Most patients spent less than a day in the intensive care unit and left the hospital within a week. No patients died during the surgery or within thirty days of the procedure, and very few experienced complications like new heart rhythm problems. At the time of discharge, nearly all patients had their valve leak reduced to a very mild level, a result that held true for the vast majority in the months immediately following the operation.
However, as the researchers looked further into the future, the picture became more nuanced. While the initial results were excellent, the durability of the repair over the long term showed some decline. By the one-year mark, the proportion of patients who remained free from a moderate or severe leak dropped, and by two years, it dropped further. The study found that the success rate was not as high as earlier reports that simply looked at patients at a single point in time might suggest. This difference occurred because some leaks returned gradually over time, a detail that only becomes clear when tracking patients continuously rather than checking them once a year. The data also revealed that the surgeons' skill improved with experience; the patients treated in the later half of the study had better long-term outcomes than those treated in the first half, suggesting that mastering the technique takes practice.
One patient in the group required a second surgery within the first year because a new cord broke, a rare but serious complication. Another patient who had a mild leak at discharge was lost to follow-up, and the researchers counted this as a failure to be safe. Despite these setbacks, the overall safety profile remained strong, with no need for blood transfusions from donors in any of the cases, as the surgeons used the patients' own blood collected during the operation. The study concludes that while this beating-heart repair is a safe and effective option for well-selected patients, it is not a permanent fix for everyone. The best results come from strict screening to ensure the patient's anatomy is right for the procedure and from careful, ongoing monitoring after surgery. The findings suggest that for those with the right heart structure, this minimally invasive method offers a powerful alternative to traditional surgery, but it requires a surgeon with significant experience and a commitment to lifelong follow-up to ensure the repair holds.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.